Top compounds associated with response to TMEM256-PLSCR3


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.002
mRNA decitabine CTRPv2 pan-cancer AAC -0.089 0.002
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.002
mRNA Vorinostat CTRPv2 pan-cancer AAC -0.11 0.002
mRNA BRD-K45681478 CTRPv2 pan-cancer AAC -0.11 0.002
mRNA apicidin CTRPv2 pan-cancer AAC -0.099 0.002
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.002
mRNA ML162 CTRPv2 pan-cancer AAC 0.11 0.003
mRNA Erlotinib gCSI pan-cancer AAC 0.18 0.003
mRNA BRD-A71883111 CTRPv2 pan-cancer AAC -0.11 0.003
Download CSV